DDR2 and carcinoid tumor: Four additional somatic mutations were detected in the DDR2 (p.Arg806Ter), CDK6 (p.Thr107Ser), and SMARCA4 gene (p.Arg1135Gln) were identified in the adenocarcinoma component, whereas no specific mutations were identified in the carcinoid component.